News Column

Research Conducted by G.A. Joanitti and Co-Researchers Has Updated Our Knowledge about Drug Delivery Systems (The emerging potential of by-products...

July 2, 2014

Research Conducted by G.A. Joanitti and Co-Researchers Has Updated Our Knowledge about Drug Delivery Systems (The emerging potential of by-products as platforms for drug delivery systems)

By a News Reporter-Staff News Editor at Biotech Week -- Investigators discuss new findings in Drugs and Therapies. According to news originating from Brasilia, Brazil, by NewsRx correspondents, research stated, "Natural resources are widely used as raw materials by industries. In most cases, abundant byproducts with low economic interest are also generated from agro-industrial supply chains."

Our news journalists obtained a quote from the research, "There are several examples for the rational use of agro-industrial byproducts in the nanobiotechnology field aiming for the development of novel products and high value added processes. Such raw materials include carapaces, pelages, blood, bagasses, and straws. Molecules from such materials (e.g. chitosan, cellulose, and albumin) are used as scaffolds of unprecedented novel nanostructure. Research efforts comprising a combination of sustainability, nanobiotechnology, and nanomedicine have emerged. One major area in nano-biotechnological research of agro-industrial byproducts is represented by the field of drug delivery systems (DDS). Among the main advantages of agro-industrial byproducts used as drug carriers are their abundance; low price; high biocompatibility; good biodegradability; moderate bioresorbability, associated with reduced systemic toxicity or even no toxicity; and often bioactivity. The goal of these efforts includes not only the possibility to characterize and manipulate matter on the nanoscale, but also to develop sustainable products and processes, including the development of platforms for drug delivery aiming for the treatment of pathologies such as cancer and diabetes. Indeed, there is great hope that the use of agro-industrial byproducts in nanobiotechnology will increase not only agricultural and livestock productivity, but will also contribute to other areas such as the development of DDS with new properties and low production costs; and sustainable environmental management due to the reuse of industrial discharged byproducts."

According to the news editors, the research concluded: "This review will compile current findings on the use of byproducts as building blocks for modern drug carrier systems, emphasizing the challenges and promising applications."

For more information on this research see: The emerging potential of by-products as platforms for drug delivery systems. Current Drug Targets, 2014;15(5):478-85. (Bentham Science Publishers -; Current Drug Targets -

The news correspondents report that additional information may be obtained from G.A. Joanitti, Laboratorio de Espectrometria de Massa, Predio da Biotecnologia, Embrapa Recursos Geneticos e Biotecnologia, Brasilia, 70770-917, DF, Brazil (see also Drugs and Therapies).

Keywords for this news article include: Brazil, Brasilia, Agriculture, South America, Bioengineering, Agro industrial, Bionanotechnology, Nanobiotechnology, Drugs and Therapies, Drug Delivery Systems, Emerging Technologies.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC

For more stories covering the world of technology, please see HispanicBusiness' Tech Channel

Source: Biotech Week

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters